Literature DB >> 26216196

Proposal of a genetic classifier for risk group stratification in pediatric T-cell lymphoblastic lymphoma reveals differences from adult T-cell lymphoblastic leukemia.

S T Balbach1, O Makarova1, B R Bonn1, M Zimmermann2, M Rohde3, I Oschlies4, W Klapper4, C Rössig1, B Burkhardt1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26216196     DOI： 10.1038/leu.2015.203

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  12 in total

1.  Loss of heterozygosity on chromosome 6q14-q24 is associated with poor outcome in children and adolescents with T-cell lymphoblastic lymphoma.

Authors:  B Burkhardt; J Bruch; M Zimmermann; K Strauch; R Parwaresch; W-D Ludwig; L Harder; B Schlegelberger; F Mueller; J Harbott; A Reiter
Journal:  Leukemia       Date:  2006-06-01       Impact factor: 11.528

2.  Whole exome sequencing hints at a unique mutational profile of paediatric T-cell lymphoblastic lymphoma.

Authors:  Bettina R Bonn; Andreas Huge; Marius Rohde; Ilske Oschlies; Wolfram Klapper; Reinhard Voss; Olga Makarova; Claudia Rossig; Heribert Jürgens; Jochen Seggewiss; Birgit Burkhardt
Journal:  Br J Haematol       Date:  2014-08-27       Impact factor: 6.998

3.  Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study.

Authors:  Martin Schrappe; Maria Grazia Valsecchi; Claus R Bartram; André Schrauder; Renate Panzer-Grümayer; Anja Möricke; Rosanna Parasole; Martin Zimmermann; Michael Dworzak; Barbara Buldini; Alfred Reiter; Giuseppe Basso; Thomas Klingebiel; Chiara Messina; Richard Ratei; Giovanni Cazzaniga; Rolf Koehler; Franco Locatelli; Beat W Schäfer; Maurizio Aricò; Karl Welte; Jacques J M van Dongen; Helmut Gadner; Andrea Biondi; Valentino Conter
Journal:  Blood       Date:  2011-06-30       Impact factor: 22.113

4.  Clinical impact of NOTCH1 and/or FBXW7 mutations, FLASH deletion, and TCR status in pediatric T-cell lymphoblastic lymphoma.

Authors:  Celine Callens; Frederic Baleydier; Etienne Lengline; Raouf Ben Abdelali; Arnaud Petit; Patrick Villarese; Agata Cieslak; Veronique Minard-Colin; Anne Rullier; Anne Moreau; André Baruchel; Claudine Schmitt; Vahid Asnafi; Yves Bertrand; Elizabeth Macintyre
Journal:  J Clin Oncol       Date:  2012-04-30       Impact factor: 44.544

5.  The significance of PTEN and AKT aberrations in pediatric T-cell acute lymphoblastic leukemia.

Authors:  Linda Zuurbier; Emanuel F Petricoin; Maartje J Vuerhard; Valerie Calvert; Clarissa Kooi; Jessica G C A M Buijs-Gladdines; Willem K Smits; Edwin Sonneveld; Anjo J P Veerman; Willem A Kamps; Martin Horstmann; Rob Pieters; Jules P P Meijerink
Journal:  Haematologica       Date:  2012-04-04       Impact factor: 9.941

6.  NOTCH1 activation clinically antagonizes the unfavorable effect of PTEN inactivation in BFM-treated children with precursor T-cell acute lymphoblastic leukemia.

Authors:  Obul R Bandapalli; Martin Zimmermann; Corinne Kox; Martin Stanulla; Martin Schrappe; Wolf-Dieter Ludwig; Rolf Koehler; Martina U Muckenthaler; Andreas E Kulozik
Journal:  Haematologica       Date:  2013-01-24       Impact factor: 9.941

7.  The role of the PTEN/AKT Pathway in NOTCH1-induced leukemia.

Authors:  Teresa Palomero; Maria Dominguez; Adolfo A Ferrando
Journal:  Cell Cycle       Date:  2008-02-19       Impact factor: 4.534

8.  RAS oncogene mutations and outcome of therapy for childhood acute lymphoblastic leukemia.

Authors:  J P Perentesis; S Bhatia; E Boyle; Y Shao; X Ou Shu; M Steinbuch; H N Sather; P Gaynon; W Kiffmeyer; J Envall-Fox; L L Robison
Journal:  Leukemia       Date:  2004-04       Impact factor: 11.528

9.  Incidence and prognostic relevance of genetic variations in T-cell lymphoblastic lymphoma in childhood and adolescence.

Authors:  Bettina R Bonn; Marius Rohde; Martin Zimmermann; David Krieger; Ilske Oschlies; Felix Niggli; Grazyna Wrobel; Andishe Attarbaschi; Gabriele Escherich; Wolfram Klapper; Alfred Reiter; Birgit Burkhardt
Journal:  Blood       Date:  2013-02-08       Impact factor: 22.113

10.  Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group.

Authors:  Birgit Burkhardt; Alfred Reiter; Eva Landmann; Peter Lang; Lisa Lassay; Roswitha Dickerhoff; Max Lakomek; Günter Henze; Arend von Stackelberg
Journal:  J Clin Oncol       Date:  2009-05-11       Impact factor: 44.544
View more
  17 in total

1.  Successful Outcomes of Newly Diagnosed T Lymphoblastic Lymphoma: Results From Children's Oncology Group AALL0434.

Authors:  Robert J Hayashi; Stuart S Winter; Kimberly P Dunsmore; Meenakshi Devidas; Zhiguo Chen; Brent L Wood; Michelle L Hermiston; David T Teachey; Sherrie L Perkins; Rodney R Miles; Elizabeth A Raetz; Mignon L Loh; Naomi J Winick; William L Carroll; Stephen P Hunger; Megan S Lim; Thomas G Gross; Catherine M Bollard
Journal:  J Clin Oncol       Date:  2020-06-17       Impact factor: 44.544

2.  Genomic and outcome analysis of adult T-cell lymphoblastic lymphoma.

Authors:  Zhaoming Li; Yue Song; Yanjie Zhang; Chaoping Li; Yingjun Wang; Weili Xue; Lisha Lu; Mengyuan Jin; Zhiyuan Zhou; Xinhua Wang; Ling Li; Lei Zhang; Xin Li; Xiaorui Fu; Zhenchang Sun; Jingjing Wu; Xudong Zhang; Hui Yu; Feifei Nan; Yu Chang; Jiaqin Yan; Xiaoyan Feng; Xiaolong Wu; Guannan Wang; Dandan Zhang; Wencai Li; Feixiang Li; Yuan Zhang; Ken H Young; Mingzhi Zhang
Journal:  Haematologica       Date:  2019-08-14       Impact factor: 9.941

Review 3.  T-cell lymphoblastic lymphoma and leukemia: different diseases from a common premalignant progenitor?

Authors:  Emma Kroeze; Jan L C Loeffen; Vera M Poort; Jules P P Meijerink
Journal:  Blood Adv       Date:  2020-07-28

Review 4.  Molecular genetics of childhood, adolescent and young adult non-Hodgkin lymphoma.

Authors:  Rodney R Miles; Rikin K Shah; J Kimble Frazer
Journal:  Br J Haematol       Date:  2016-03-11       Impact factor: 6.998

Review 5.  Childhood, adolescent and young adult non-Hodgkin lymphoma: current perspectives.

Authors:  Mitchell S Cairo; Auke Beishuizen
Journal:  Br J Haematol       Date:  2019-02-06       Impact factor: 6.998

6.  Genomic landscape of T-cell lymphoblastic lymphoma.

Authors:  Zhaoming Li; Yue Song; Mingzhi Zhang; Yiming Wei; Hang Ruan
Journal:  Chin J Cancer Res       Date:  2022-04-30       Impact factor: 4.026

Review 7.  Paediatric non-Hodgkin lymphoma - perspectives in translational biology.

Authors:  Bruce Shiramizu; Lara Mussolin; Wilhelm Woessmann; Wolfram Klapper
Journal:  Br J Haematol       Date:  2016-03-24       Impact factor: 6.998

8.  Treatment and Outcome Analysis of 639 Relapsed Non-Hodgkin Lymphomas in Children and Adolescents and Resulting Treatment Recommendations.

Authors:  Birgit Burkhardt; Mary Taj; Nathalie Garnier; Veronique Minard-Colin; Volkan Hazar; Karin Mellgren; Tomoo Osumi; Alina Fedorova; Natalia Myakova; Jaime Verdu-Amoros; Mara Andres; Edita Kabickova; Andishe Attarbaschi; Alan Kwok Shing Chiang; Eva Bubanska; Svetlana Donska; Lisa Lyngsie Hjalgrim; Jacek Wachowiak; Anna Pieczonka; Anne Uyttebroeck; Jelena Lazic; Jan Loeffen; Jochen Buechner; Felix Niggli; Monika Csoka; Gergely Krivan; Julia Palma; G A Amos Burke; Auke Beishuizen; Kristin Koeppen; Stephanie Mueller; Heidi Herbrueggen; Wilhelm Woessmann; Martin Zimmermann; Adriana Balduzzi; Marta Pillon
Journal:  Cancers (Basel)       Date:  2021-04-25       Impact factor: 6.639

9.  Integrative genomic analysis of pediatric T-cell lymphoblastic lymphoma reveals candidates of clinical significance.

Authors:  Tasneem Khanam; Sarah Sandmann; Jochen Seggewiss; Charlotte Ruether; Martin Zimmermann; Allison B Norvil; Christoph Bartenhagen; Gerrit Randau; Stephanie Mueller; Heidi Herbrueggen; Per Hoffmann; Stefan Herms; Lanying Wei; Marius Woeste; Christian Wuensch; Humaira Gowher; Ilske Oschlies; Wolfram Klapper; Wilhelm Woessmann; Martin Dugas; Birgit Burkhardt
Journal:  Blood       Date:  2021-04-29       Impact factor: 22.113

Review 10.  PTEN in Regulating Hematopoiesis and Leukemogenesis.

Authors:  Yilin Wu; Haichuan Zhu; Hong Wu
Journal:  Cold Spring Harb Perspect Med       Date:  2020-10-01       Impact factor: 5.159
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.